173.809 articles found

Bacteria‐Derived 1‐Allylpiperazine Alleviates Symptoms of Parkinson's Disease Model by Promoting Autophagy

Qu M, Zhang X, Chen X, Shi J, Xu M, Wang F, Lv J, Sun J, Niu W, Liu Z, Li L, Liu F, Wang X.

Advanced Science · 2026-10-08

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis.

D'Souza L, Niharika BR, Benito-León J, Samarth BR, Das R, Kotwal M, Reddy K, Katti PA, Bhat CSP.

Tremor Other Hyperkinet Mov (N Y) · 2026-10-08

DOI: 10.5334/tohm.1278PMID: 42857721

Tegmental atrophy in isolated REM sleep behaviour disorder: <i>ex vivo</i> MRI-informed <i>in vivo</i> imaging.

Hirose M, Yoshinaga K, Mori Y, Shima A, Sawamoto N, Wakasugi N, Imai H, Watanabe M, Beck G, Kajiyama Y, Nishiike U, Mochizuki H, Kawabata K, Hiraga K, Nakamura T, Katsuno M, Watanabe H, Hatano T, Kamagata K, Hattori N, Nishida A, Mukai Y, Minakawa EN, Takahashi Y, Takahashi R, Hanakawa T.

Brain Commun · 2026-10-08

DOI: 10.1093/braincomms/fcag379PMID: 42921079

Dibucaine induces autophagic flux and reduces Ser129-phosphorylated <i>α</i>-synuclein in induced pluripotent stem cell-derived neurons with <i>SNCA</i> duplication.

Kitagawa M, Miyamoto K, Yoshida K, Ishikawa KI, Sasazawa Y, Akamatsu W, Saiki S, Hatano T, Imoto M, Nagata H, Hattori N.

Front Neurol · 2026-10-08

DOI: 10.3389/fneur.2026.1891393PMID: 42922803

Research on dynamic functional connectivity and graph theoretic features of different motor subtypes in Parkinson's disease based on ICA.

Tang J, Gao S, Lv Y, Wang H, Liu Y, Zhou H, Yuan J, Lin X, Hu M, Cong Y, Wang X.

Front Neurol · 2026-10-08

DOI: 10.3389/fneur.2026.1943343PMID: 42922813

Wearable sensor-derived gait signatures for Parkinson's disease: an exploratory diagnostic study integrating dimensionality reduction and machine learning.

Hong G, Wen X, Gao J, Lin J, Zumulaiti S, Yang Y, Xiao X.

Front Med (Lausanne) · 2026-10-08

DOI: 10.3389/fmed.2026.1939598PMID: 42923105

Assessment of the transcriptional and cellular effects of CRISPRa targeting Dopa decarboxylase and GTP cyclohydrolase 1 in HEK293 and SH-SY5Y cellular models of Parkinsonian neurotoxicity.

Bhengu SZ, Singh R, Ramsuran V, Msibi ZNP.

Front Cell Neurosci · 2026-10-08

DOI: 10.3389/fncel.2026.1883789PMID: 42923163

Psychotic symptoms in tyrosine hydroxylase deficiency-associated dopa-responsive dystonia treated with antipsychotics and rTMS: a case report.

Shen Y, Chen HZ, Lv L, Fang LL.

Front Psychiatry · 2026-10-08

DOI: 10.3389/fpsyt.2026.1920048PMID: 42923261

Digital health meets Parkinson's disease: a bibliometric exploration of wearable sensors research and emerging frontiers (2005-2026).

Xiong L.

Front Neuroinform · 2026-10-08

DOI: 10.3389/fninf.2026.1937585PMID: 42923510

RVG29-functionalized nanocarriers for brain-targeted therapy of neurodegenerative diseases: mechanisms, therapeutic advances, and translational perspectives.

Gandhi SM, Patel S, Haswani NG, Wahab S, Sabah ZU, Kapoor DU.

Naunyn Schmiedebergs Arch Pharmacol · 2026-10-08

DOI: 10.1007/s00210-026-05958-7PMID: 42844308

Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.

Corvol JC, Tesson C, Liot S, Carvalho S, Castelnovo G, Damier P, Defebvre L, Giordana C, Houeto JL, Marques A, Meissner WG, Remy P, Thobois S, Fabbri M, Rascol O, NS‐PARK cohort.

Mov Disord · 2026-10-08

DOI: 10.1002/mds.70537PMID: 42845097

Continuous Subcutaneous Apomorphine as a Temporary Bridging Therapy for Dopamine Dysregulation Syndrome in Patients with Deep Brain Stimulation.

Binder T, Hartig J, Sitzmann L, Ip CW, Capetian P, Lange F, Reich M, Daniels C, Volkmann J.

Mov Disord Clin Pract · 2026-10-08

DOI: 10.1002/mdc3.70831PMID: 42845107